Chemical metabolic inhibitors for the treatment of blood-borne cancers . Anti-cancer agents in medicinal chemistry, pp.223-232, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-01867009
On respiratory impairment in cancer cells, Science, vol.124, pp.269-270, 1956. ,
From tumor cell metabolism to tumor immune escape, The International Journal of Biochemistry & Cell Biology, vol.45, issue.1, pp.106-113, 2013. ,
DOI : 10.1016/j.biocel.2012.04.024
URL : https://hal.archives-ouvertes.fr/inserm-00726717
Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia, Leukemia, vol.351, issue.10, pp.1731-1737, 2006. ,
DOI : 10.1056/NEJMoa033513
URL : http://www.nature.com/leu/journal/v20/n10/pdf/2404365a.pdf
The Warburg Effect in Leukemia-Stroma Cocultures Is Mediated by Mitochondrial Uncoupling Associated with Uncoupling Protein 2 Activation, Cancer Research, vol.68, issue.13, pp.5198-5205, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-0555
Oxidative Phosphorylation Induces De Novo Expression of the MHC Class I in Tumor Cells through the ERK5 Pathway, The Journal of Immunology, vol.185, issue.6, pp.3498-3503, 2010. ,
DOI : 10.4049/jimmunol.1001250
Evaluation of Long-term Treatment of Children With Congenital Lactic Acidosis With Dichloroacetate, PEDIATRICS, vol.121, issue.5, pp.1223-1228, 2008. ,
DOI : 10.1542/peds.2007-2062
Role of dichloroacetate in the treatment of genetic mitochondrial diseases???, Advanced Drug Delivery Reviews, vol.60, issue.13-14, pp.1478-1487, 2008. ,
DOI : 10.1016/j.addr.2008.02.014
Metabolic Modulation of Glioblastoma with Dichloroacetate, Science Translational Medicine, vol.462, issue.7274, pp.31-34, 2010. ,
DOI : 10.1038/nature08617
Non-Hodgkin's Lymphoma Reversal with Dichloroacetate, Journal of Oncology, vol.33, issue.3, 2010. ,
DOI : 10.1016/0021-9150(79)90180-1
Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate, Oncogene, vol.141, issue.38, pp.4026-4037, 2011. ,
DOI : 10.1007/s11010-010-0397-6
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth, Cancer Cell, vol.11, issue.1, pp.37-51, 2007. ,
DOI : 10.1016/j.ccr.2006.10.020
URL : https://doi.org/10.1016/j.ccr.2006.10.020
Medullary thyroid carcinoma relapse reversed with dichloroacetate: A case report, Oncology Letters, vol.1, issue.5, pp.889-891, 2010. ,
DOI : 10.3892/ol_00000158
Severe encephalopathy and polyneuropathy induced by dichloroacetate, Journal of Neurology, vol.324, issue.31, pp.2099-2100, 2010. ,
DOI : 10.1126/scitranslmed.3000677
Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs, Cancer Chemotherapy and Pharmacology, vol.329, issue.3, pp.647-655, 2011. ,
DOI : 10.1016/j.crvi.2005.08.007
URL : https://hal.archives-ouvertes.fr/hal-00595954
Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC, International Journal of Cancer, vol.283, issue.11, pp.2510-2519, 2010. ,
DOI : 10.1042/bj1410761
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.25499/pdf
p53 regulation of metabolic pathways . Cold Spring Harbor perspectives in biology, p.1040, 2010. ,
DOI : 10.1101/cshperspect.a001040
URL : http://cshperspectives.cshlp.org/content/2/4/a001040.full.pdf
The Role of p53 in Metabolic Regulation, Genes & Cancer, vol.2, issue.4, pp.385-391, 2011. ,
DOI : 10.1177/1947601911409738
The Regulation of AMPK ??1, TSC2, and PTEN Expression by p53: Stress, Cell and Tissue Specificity, and the Role of These Gene Products in Modulating the IGF-1-AKT-mTOR Pathways, Cancer Research, vol.67, issue.7, pp.3043-3053, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-4149
Hypoxia Triggers AMPK Activation through Reactive Oxygen Species-Mediated Activation of Calcium Release-Activated Calcium Channels, Molecular and Cellular Biology, vol.31, issue.17, pp.3531-3545, 2011. ,
DOI : 10.1128/MCB.05124-11
URL : http://mcb.asm.org/content/31/17/3531.full.pdf
AMP-Activated Protein Kinase Induces a p53-Dependent Metabolic Checkpoint, Molecular Cell, vol.18, issue.3, pp.283-293, 2005. ,
DOI : 10.1016/j.molcel.2005.03.027
URL : https://doi.org/10.1016/j.molcel.2005.03.027
p53 mutations in human cancers, Science, vol.253, issue.5015, pp.49-53, 1991. ,
DOI : 10.1126/science.1905840
URL : https://zenodo.org/record/1230948/files/article.pdf
p53 mutations in cancer, Nature Cell Biology, vol.19, issue.1, pp.2-8, 2013. ,
DOI : 10.1038/sj.onc.1201857
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities, Cancer Cell, vol.25, issue.3, pp.304-317, 2014. ,
DOI : 10.1016/j.ccr.2014.01.021
URL : https://doi.org/10.1016/j.ccr.2014.01.021
Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation, Molecular Cell, vol.54, issue.6, pp.960-974, 2014. ,
DOI : 10.1016/j.molcel.2014.04.024
URL : https://doi.org/10.1016/j.molcel.2014.04.024
Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia, Blood, vol.84, pp.3105-3112, 1994. ,
p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression, Blood, vol.82, pp.3452-3459, 1993. ,
Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage, Blood, vol.16, issue.9, pp.5307-5314, 2009. ,
DOI : 10.1128/MCB.16.9.4952
p53 mutation is associated with progression in follicular lymphomas, Blood, vol.82, pp.1994-2004, 1993. ,
The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-indepen- dent ILF3/p21 pathway, Oncotarget, 2014. ,
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3, Oncotarget, vol.5, issue.12, pp.4347-4360, 2014. ,
DOI : 10.18632/oncotarget.2018
Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer, Oncogene, vol.30, issue.13, pp.1638-1650, 2013. ,
DOI : 10.1038/onc.2011.113
Role of AMP-activated protein kinase in mechanism of metformin action, Journal of Clinical Investigation, vol.108, issue.8, pp.1167-1174, 2001. ,
DOI : 10.1172/JCI13505
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation, Blood, vol.22, issue.9, pp.4262-4273, 2010. ,
DOI : 10.1038/leu.2008.144
Activation of AMP-activated Protein Kinase Induces p53-dependent Apoptotic Cell Death in Response to Energetic Stress, Journal of Biological Chemistry, vol.62, issue.7, pp.3979-3987, 2008. ,
DOI : 10.1074/jbc.M606357200
Polygonatum cyrtonema lectin induces apoptosis and autophagy in human melanoma A375 cells through a mitochondria-mediated ROS???p38???p53 pathway, Cancer Letters, vol.275, issue.1, pp.54-60, 2009. ,
DOI : 10.1016/j.canlet.2008.09.042
ROS and p53: A versatile partnership, Free Radical Biology and Medicine, vol.44, issue.8, pp.1529-1535, 2008. ,
DOI : 10.1016/j.freeradbiomed.2008.01.011
URL : http://europepmc.org/articles/pmc2359898?pdf=render
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function, Proceedings of the National Academy of Sciences, vol.43, issue.42, pp.7455-7460, 2010. ,
DOI : 10.1021/bi048560o
URL : http://www.pnas.org/content/107/16/7455.full.pdf
The antioxidant function of the p53 tumor suppressor, Nature Medicine, vol.56, issue.12, pp.1306-1313, 2005. ,
DOI : 10.1038/nature01819
The NF-??B member p65 controls glutamine metabolism through miR-23a, The International Journal of Biochemistry & Cell Biology, vol.44, issue.9, pp.1448-1456, 2012. ,
DOI : 10.1016/j.biocel.2012.05.011
Extracellular-signal-regulated kinase 5 modulates the antioxidant response by transcriptionally controlling Sirtuin 1 expression in leukemic cells, The International Journal of Biochemistry & Cell Biology, vol.53, pp.253-261, 2014. ,
DOI : 10.1016/j.biocel.2014.05.026
URL : https://hal.archives-ouvertes.fr/inserm-01867017
-related strains, International Journal of Cancer, vol.87, issue.9, pp.2222-2227, 2008. ,
DOI : 10.1016/S0002-9440(10)65022-5
Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm, Clinical Cancer Research, vol.17, issue.19, pp.6163-6173, 2011. ,
DOI : 10.1158/1078-0432.CCR-11-0212
Mutant p53: one name, many proteins, Genes & Development, vol.26, issue.12, pp.1268-1286, 2012. ,
DOI : 10.1101/gad.190678.112
URL : http://genesdev.cshlp.org/content/26/12/1268.full.pdf
Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells, Molecular Cancer Research, vol.9, issue.5, pp.577-588, 2011. ,
DOI : 10.1158/1541-7786.MCR-10-0534
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C, Leukemia, vol.265, issue.4, pp.610-619, 2006. ,
DOI : 10.1074/jbc.M309054200
URL : http://www.nature.com/leu/journal/v20/n4/pdf/2404140a.pdf
Human leukemias with mutated FLT3 kinase are synergistically sensitive to FLT3 and Hsp90 inhibitors: the key role of the STAT5 signal transduction pathway, Leukemia, vol.103, issue.9, pp.1605-1612, 2005. ,
DOI : 10.1182/blood-2003-02-0418
FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction-associated kinases, Clin Cancer Res, vol.9, pp.4483-4493, 2003. ,
Tumor suppressors and cell metabolism: a recipe for cancer growth, Genes & Development, vol.23, issue.5, pp.537-548, 2009. ,
DOI : 10.1101/gad.1756509
URL : http://genesdev.cshlp.org/content/23/5/537.full.pdf
Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species, Proceedings of the National Academy of Sciences, vol.264, issue.41, pp.7461-7466, 2010. ,
DOI : 10.1016/S0076-6879(96)64044-0
URL : http://www.pnas.org/content/107/16/7461.full.pdf
p53 Regulates Mitochondrial Respiration, Science, vol.312, issue.5780, pp.1650-1653, 2006. ,
DOI : 10.1126/science.1126863
Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation, Oncogene, vol.55, issue.11, pp.1641-1652, 2010. ,
DOI : 10.1016/j.cell.2005.06.009
URL : http://www.nature.com/onc/journal/v29/n11/pdf/onc2009448a.pdf
Blinded by the Light: The Growing Complexity of p53, Cell, vol.137, issue.3, pp.413-431, 2009. ,
DOI : 10.1016/j.cell.2009.04.037
Glucose Catabolism in Cancer Cells, Journal of Biological Chemistry, vol.44, issue.36, pp.22776-22780, 1997. ,
DOI : 10.1007/978-3-662-22275-1
URL : http://www.jbc.org/content/276/46/43407.full.pdf
THE CLINICAL SIGNIFICANCE OF MUTATIONS OF THE P52 TUMOUR SUPPRESSOR GENE IN HAEMATOLOGICAL MALIGNANCIES, British Journal of Haematology, vol.98, issue.3, pp.502-511, 1997. ,
DOI : 10.1046/j.1365-2141.1997.2403057.x
ERK5 Knockdown Generates Mouse Leukemia Cells with Low MHC Class I Levels That Activate NK Cells and Block Tumorigenesis, The Journal of Immunology, vol.182, issue.6, pp.3398-3405, 2009. ,
DOI : 10.4049/jimmunol.0803006
URL : https://hal.archives-ouvertes.fr/hal-00368654
MdmX is a substrate for the deubiquitinating enzyme USP2a, Oncogene, vol.7, issue.3, pp.432-441, 2010. ,
DOI : 10.1038/sj.onc.1204656
URL : http://www.nature.com/onc/journal/v29/n3/pdf/onc2009330a.pdf
p53 mutant breast cancer patients expressing p53?? have as good a prognosis as wild-type p53 breast cancer patients, Breast Cancer Research, vol.56, issue.1, p.7, 2011. ,
DOI : 10.1111/j.1365-2559.2010.03533.x
URL : https://hal.archives-ouvertes.fr/inserm-00663689
Rheb Regulates Mitophagy Induced by Mitochondrial Energetic Status, Cell Metabolism, vol.17, issue.5, pp.719-730, 2013. ,
DOI : 10.1016/j.cmet.2013.03.014
URL : https://hal.archives-ouvertes.fr/hal-00905845